Fullerene (C60) immunoconjugates: interaction of water-soluble C60 derivatives with the murine anti-gp240 melanoma antibody.
The first fullerene (C60) immunoconjugates have been prepared and characterized as an initial step toward the development of fullerene immunotherapy (FIT).
Ashcroft
Jared M
JM
Department of Chemistry, Smalley Institute for Nanoscale Science and Technology, and the Center for Biological and Environmental Nanotechnology, MS 60, Rice University, Houston, Texas 77005, USA.
Tsyboulski
Dmitri A
DA
Hartman
Keith B
KB
Zakharian
Tatiana Y
TY
Marks
John W
JW
Weisman
R Bruce
RB
Rosenblum
Michael G
MG
Wilson
Lon J
LJ
D000818:Animals; D000911:Antibodies, Monoclonal / Q000378:metabolism*; D000912:Antibodies, Neoplasm / Q000378:metabolism*; D037741:Fullerenes / Q000737:chemistry / Q000276:immunology / Q000378:metabolism*; D018796:Immunoconjugates / Q000276:immunology / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy; D008545:Melanoma / Q000276:immunology; D051379:Mice; D011509:Proteoglycans / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000912:Antibodies, Neoplasm; D037741:Fullerenes; D018796:Immunoconjugates; D011509:Proteoglycans; C094441:gp240 glycoprotein, human; C069837:fullerene C60